Correlation Between Combigene and Kancera AB

Can any of the company-specific risk be diversified away by investing in both Combigene and Kancera AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Combigene and Kancera AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Combigene AB and Kancera AB, you can compare the effects of market volatilities on Combigene and Kancera AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Combigene with a short position of Kancera AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Combigene and Kancera AB.

Diversification Opportunities for Combigene and Kancera AB

-0.22

Correlation Coefficient

Combigene  Kancera AB

Very good diversification

The 3 months correlation between Combigene and Kancera is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Combigene AB and Kancera AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kancera AB and Combigene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Combigene AB are associated (or correlated) with Kancera AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kancera AB has no effect on the direction of Combigene i.e., Combigene and Kancera AB go up and down completely randomly.

Pair Corralation between Combigene and Kancera AB

Assuming the 90 days trading horizon Combigene AB is expected to under-perform the Kancera AB. But the stock apears to be less risky and, when comparing its historical volatility, Combigene AB is 2.08 times less risky than Kancera AB. The stock trades about -0.01 of its potential returns per unit of risk. The Kancera AB is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  122.00  in Kancera AB on April 24, 2025 and sell it today you would earn a total of  31.00  from holding Kancera AB or generate 25.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Combigene AB  vs.  Kancera AB

Combigene AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days Combigene AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Combigene is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Kancera AB

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Kancera AB are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Kancera AB unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Combigene and Kancera AB

The main advantage of trading using opposite Combigene and Kancera AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Combigene position performs unexpectedly, Kancera AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kancera AB will offset losses from the drop in Kancera AB's long position.

The idea behind Combigene AB and Kancera AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .